166 related articles for article (PubMed ID: 34623039)
1. Contiguous squamous proliferations in syringocystadenoma papilliferum: A retrospective study of 14 cases.
Aggarwal D; Chatterjee D; Keshavamurthy V; Chhikara K; Saikia UN; Radotra BD; De D; Singh MP
Indian J Dermatol Venereol Leprol; 2023; 89(2):266-273. PubMed ID: 34623039
[TBL] [Abstract][Full Text] [Related]
2. Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry.
Friedman BJ; Sahu J; Solomides CC; Connolly DM; Lee JB
J Cutan Pathol; 2018 Mar; 45(3):212-216. PubMed ID: 29206289
[TBL] [Abstract][Full Text] [Related]
3. Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases.
Alegría-Landa V; Jo-Velasco M; Santonja C; Eraña I; Vergara-Sanchez A; Kutzner H; Requena L
J Cutan Pathol; 2020 Jan; 47(1):12-16. PubMed ID: 31449665
[TBL] [Abstract][Full Text] [Related]
4. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
[TBL] [Abstract][Full Text] [Related]
5. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
6. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components.
Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H
J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472
[No Abstract] [Full Text] [Related]
7. Syringocystadenoma papilliferum of the scalp.
Perlman KL; Kentosh JB
Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865286
[TBL] [Abstract][Full Text] [Related]
8. Syringocystadenoma Papilliferum Revealed 12 Years After Surgical Treatment of Chronic Ear with Cholesteatoma: Presentation of an Unusual Case and Literature Review.
Zwierz A; Masna K; Burduk P
J Int Adv Otol; 2022 Nov; 18(6):544-547. PubMed ID: 36349679
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
[No Abstract] [Full Text] [Related]
10. Syringocystadenoma papilliferum and trichoblastoma arising in the nevus sebaceous.
Wang F; Wu Y; Zheng Z; Bai Y
Indian J Pathol Microbiol; 2018; 61(1):106-108. PubMed ID: 29567896
[TBL] [Abstract][Full Text] [Related]
11. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
Blind A; Weingertner N; Cribier B
Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
[TBL] [Abstract][Full Text] [Related]
12. Dermoscopy of syringocystadenoma papilliferum.
Lombardi M; Piana S; Longo C; Borsari S; Persechino F; Argenziano G; Moscarella E
Australas J Dermatol; 2018 Feb; 59(1):e59-e61. PubMed ID: 28695704
[TBL] [Abstract][Full Text] [Related]
13. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes.
Hsieh MS; Bishop JA; Wang YP; Poh CF; Cheng YL; Lee YH; Jin YT; Chang JYF
Head Neck Pathol; 2020 Jun; 14(2):489-496. PubMed ID: 31473937
[TBL] [Abstract][Full Text] [Related]
14. Syringocystadenoma Papilliferum in the External Ear Canal.
Jakovljevic S; Arsovic N; Boricic N; Laketic D; Dudvarski Z
Arch Iran Med; 2022 Sep; 25(9):658-660. PubMed ID: 37543891
[TBL] [Abstract][Full Text] [Related]
15. Syringocystadenoma Papilliferum of the External Auditory Canal.
Bruschini L; Ciabotti A; De Vito A; Forli F; Cambi C; Ciancia EM; Berrettini S
Am J Case Rep; 2017 May; 18():520-524. PubMed ID: 28490727
[TBL] [Abstract][Full Text] [Related]
16. Syringocystadenoma papilliferum arising in a naevus sebaceous.
Faheem NAA; Kwan Z; Yong ASW; Ch'ng CC; Tan KK; Naicker M; Tan LL
Malays J Pathol; 2019 Apr; 41(1):47-49. PubMed ID: 31025637
[TBL] [Abstract][Full Text] [Related]
17. Syringocystadenoma papilliferum of the eyelid.
Barbarino S; McCormick SA; Lauer SA; Milman T
Ophthalmic Plast Reconstr Surg; 2009; 25(3):185-8. PubMed ID: 19454927
[TBL] [Abstract][Full Text] [Related]
18. Intradermal Syringocystadenoma Papilliferum on the Popliteal Fossa: A Rare Dermal Variant in an Atypical Location.
Omer M; Na S; Joshipura D; Robinson-Bostom L
R I Med J (2013); 2024 Jul; 107(7):14-16. PubMed ID: 38917308
[TBL] [Abstract][Full Text] [Related]
19. Complex sweat gland hamartoma: A case report.
Skopec Z; Berrebi KG; Stone M; Liu V
J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
[TBL] [Abstract][Full Text] [Related]
20. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
